Healthcare Infection Control Practices Advisory Committee, 26547-26548 [2023-09063]
Download as PDF
<![CDATA[
26547
Federal Register / Vol. 88, No. 83 / Monday, May 1, 2023 / Notices
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
(EMTAs) will use the PHEM Tool to
guide an in-person interview with
GHSA countries Ministry of Health,
Public Health Emergency Operations
Center (PHEOC) Manager, and optional
additional staff, to characterize the
country’s PHEM program and
capabilities. EMTAs will document
responses in an excel based form that
will be entered into and maintained in
the CDCReady data base. Collected data
will identify strengths and weaknesses,
capabilities, and gaps in PHEM
programs and PHEOCs in GHSA
countries. Findings will guide GEMCD
team program planning initiatives and
determine appropriate technical
assistance (TA) for GHSA countries.
Data will be analyzed to identify the
presence or absence of specific PHEM
and PHEOC requirements, such as
plans, policies, and procedures, etc.
Additional analysis will focus upon the
status of PHEM and PHEOC plans,
policies, and procedures (e.g., date of
publication, relevance). The survey will
be conducted annually to identify
progress and document changes from
one year to the next in terms of PHEM
program and PHEOC capabilities.
OMB approval is requested for three
years. The estimated annualized burden
for this information collection is 72
hours. There is no cost to respondents
other than their time.
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Public Health Emergency
Management Capacity Assessment Tool
(PHEM Tool)—New—Office of
Readiness and Response (ORR), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
The Center for Disease Control and
Prevention’s (CDC) Global Emergency
Management Capacity Development
(GEMCD) team strengthens emergency
management capacity development
globally. It helps countries to prepare
for, anticipate, and respond to all forms
of public health threats. GEMCD’s
mission is to build resilient Public
Health Emergency Management (PHEM)
programs throughout the world.
The GEMCD team’s Emergency
Management Technical Advisors
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
burden per
response
(in hours)
Total burden
(in hours)
Form name
Ministry of Health personnel responsible for Public Health Emergency Management (PHEM)
Program in participating GHSA countries.
PHEM Tool ...................
12
1
6
72
Total ...............................................................
.......................................
........................
........................
........................
72
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2023–09087 Filed 4–28–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
responses per
respondent
Type of respondents
In accordance with regulatory
provisions, the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
SUMMARY:
VerDate Sep<11>2014
17:10 Apr 28, 2023
Jkt 259001
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
Healthcare Infection Control Practices
Advisory Committee (HICPAC). This
virtual meeting is open to the public,
limited only by room seating available
(120). The public is also welcomed to
listen to the meeting via Zoom; 500
teleconference lines are available. Time
will be available for public comment.
Registration is required.
DATES: The meeting will be held on June
8, 2023, 9 a.m. to 5 p.m., EDT, and June
9, 2023, 9 a.m. to 12 p.m., EDT.
ADDRESSES: Registration is required to
attend in person or on the phone.
Interested parties must be processed in
accordance with established federal
policies and procedures and may
E:\FR\FM\01MYN1.SGM
01MYN1
26548
Federal Register / Vol. 88, No. 83 / Monday, May 1, 2023 / Notices
lotter on DSK11XQN23PROD with NOTICES1
register at https://www.cdc.gov/hicpac.
All registered participants will receive
instructions shortly before the meeting.
Please click first link for day one and
the second link for day two to join the
webinar:
https://cdc.zoomgov.com/j/
1616828862?pwd=N3hmSTEvQjQ3ZHF
ScVMyM1k2Mk8yUT09.
Meeting ID: 161 682 8862.
Passcode: 74249065.
https://cdc.zoomgov.com/j/
1614944394?pwd=
UWdBRDNNK2pDdS9
PMjlMZzYvRVFzZz09.
Meeting ID: 161 494 4394.
Passcode: 26658671.
FOR FURTHER INFORMATION CONTACT:
Sydnee Byrd, M.P.A., HICPAC, National
Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention, l600
Clifton Road NE, Mailstop H16–3,
Atlanta, Georgia 30329. Telephone (404)
718–8039; Email: hicpac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion, the Director,
NCEZID, the Director, CDC, and the
Secretary, Health and Human Services,
regarding (1) the practice of healthcare
infection prevention and control; (2)
strategies for surveillance, prevention,
and control of infections, antimicrobial
resistance, and related events in settings
where healthcare is provided; and (3)
periodic updating of CDC guidelines
and other policy statements regarding
prevention of healthcare-associated
infections and healthcare-related
conditions.
Matters To Be Considered: The agenda
will include updates on CDC’s activities
for prevention of healthcare-associated
infections. It will also include updates
from the following HICPAC workgroups:
the Isolation Precautions Guideline
workgroup, the Dental Unit Waterline
Guideline Workgroup, the Healthcare
Personnel Guideline Workgroup, the
Neonatal Intensive Care Unit Guideline
Workgroup, and the National Healthcare
Safety Network Workgroup. The agenda
also includes updates on CDC and
DHQP activities. Agenda items are
subject to change as priorities dictate.
Public Participation
Oral Public Comment: Time will be
available for public comment. Members
of the public who wish to provide
public comments should plan to attend
the public comment session at the start
time listed. Please note that the public
comment period may end before the
time indicated, following the last call
for comments.
VerDate Sep<11>2014
17:10 Apr 28, 2023
Jkt 259001
Written Public Comment: The public
is welcomed to submit written
comments in advance of the meeting.
Comments should be submitted in
writing by email to the contact person
listed above. The deadline for receipt of
written public comment is May 26,
2023. All requests must contain the
name, address, and organizational
affiliation of the speaker, as well as the
topic being addressed. Written
comments should not exceed one singlespaced typed page in length and
delivered in 3 minutes or less. Written
comments received in advance of the
meeting will be included in the official
record of the meeting.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–09063 Filed 4–28–23; 8:45 am]
BILLING CODE 4163–19–P
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC); Notice of Charter
Renewal
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of charter renewal.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), within
the Department of Health and Human
Services (HHS), announces the renewal
of the charter of the Advisory
Committee to the Director (ACD).
FOR FURTHER INFORMATION CONTACT:
Bridget Richards, MPH, Office of the
Chief of Staff, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop H21–10, Atlanta,
Georgia 30329–4027; Telephone: (404)
718–5028; Email: ACDirector@cdc.gov.
SUPPLEMENTARY INFORMATION: CDC is
providing notice under 5 U.S.C. 1001–
1014. This charter has been renewed for
SUMMARY:
Frm 00033
Fmt 4703
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–09071 Filed 4–28–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Mine Safety and Health Research
Advisory Committee
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with regulatory
provisions, the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
Mine Safety and Health Research
Advisory Committee (MSHRAC). This is
a hybrid meeting, accessible both in
person and virtually. It is open to the
public and limited only by the space
available and the number of web
conference lines available. Time will be
available for public comment.
DATES: The meeting will be held on May
24, 2023, from 8:30 a.m. to 4:25 p.m.,
PDT.
ADDRESSES: Centers for Disease Control
and Prevention, National Institute for
Occupational Safety and Health,
Spokane Campus, 315 East Montgomery
Avenue, Spokane, Washington 99207–
2291. The conference room space
accommodates approximately 49
people.
Please note that the meeting location
is a federal facility, and in-person access
is limited to United States citizens
unless prior authorizations, taking up to
30 days, have been made.
If you wish to attend the meeting,
either in person or virtually, please
contact Ms. Berni Metzger by email at
Metzger@cdc.gov or by phone at (412)
386–4541 at least 5 business days in
advance of the meeting. If you are
SUMMARY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
a two-year period through April 15,
2025.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sfmt 4703
E:\FR\FM\01MYN1.SGM
01MYN1
]]>Agencies
[Federal Register Volume 88, Number 83 (Monday, May 1, 2023)]
[Notices]
[Pages 26547-26548]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-09063]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention (CDC) announces the following meeting
for the Healthcare Infection Control Practices Advisory Committee
(HICPAC). This virtual meeting is open to the public, limited only by
room seating available (120). The public is also welcomed to listen to
the meeting via Zoom; 500 teleconference lines are available. Time will
be available for public comment. Registration is required.
DATES: The meeting will be held on June 8, 2023, 9 a.m. to 5 p.m., EDT,
and June 9, 2023, 9 a.m. to 12 p.m., EDT.
ADDRESSES: Registration is required to attend in person or on the
phone. Interested parties must be processed in accordance with
established federal policies and procedures and may
[[Page 26548]]
register at https://www.cdc.gov/hicpac. All registered participants
will receive instructions shortly before the meeting. Please click
first link for day one and the second link for day two to join the
webinar:
https://cdc.zoomgov.com/j/1616828862?pwd=N3hmSTEvQjQ3ZHFScVMyM1k2Mk8yUT09.
Meeting ID: 161 682 8862.
Passcode: 74249065.
https://cdc.zoomgov.com/j/1614944394?pwd=UWdBRDNNK2pDdS9PMjlMZzYvRVFzZz09.
Meeting ID: 161 494 4394.
Passcode: 26658671.
FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., HICPAC, National
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention, l600 Clifton Road NE, Mailstop H16-
3, Atlanta, Georgia 30329. Telephone (404) 718-8039; Email:
[email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion, the
Director, NCEZID, the Director, CDC, and the Secretary, Health and
Human Services, regarding (1) the practice of healthcare infection
prevention and control; (2) strategies for surveillance, prevention,
and control of infections, antimicrobial resistance, and related events
in settings where healthcare is provided; and (3) periodic updating of
CDC guidelines and other policy statements regarding prevention of
healthcare-associated infections and healthcare-related conditions.
Matters To Be Considered: The agenda will include updates on CDC's
activities for prevention of healthcare-associated infections. It will
also include updates from the following HICPAC workgroups: the
Isolation Precautions Guideline workgroup, the Dental Unit Waterline
Guideline Workgroup, the Healthcare Personnel Guideline Workgroup, the
Neonatal Intensive Care Unit Guideline Workgroup, and the National
Healthcare Safety Network Workgroup. The agenda also includes updates
on CDC and DHQP activities. Agenda items are subject to change as
priorities dictate.
Public Participation
Oral Public Comment: Time will be available for public comment.
Members of the public who wish to provide public comments should plan
to attend the public comment session at the start time listed. Please
note that the public comment period may end before the time indicated,
following the last call for comments.
Written Public Comment: The public is welcomed to submit written
comments in advance of the meeting. Comments should be submitted in
writing by email to the contact person listed above. The deadline for
receipt of written public comment is May 26, 2023. All requests must
contain the name, address, and organizational affiliation of the
speaker, as well as the topic being addressed. Written comments should
not exceed one single-spaced typed page in length and delivered in 3
minutes or less. Written comments received in advance of the meeting
will be included in the official record of the meeting.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-09063 Filed 4-28-23; 8:45 am]
BILLING CODE 4163-19-P
